JRONF(JRONF)
JRONF
No analyst ratings available
No analyst price targets available for JRONF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $38.16B | $40.49B | $42.96B | $45.97B | $49.08B |
| Low | $37.54B | $39.37B | $42.01B | $44.96B | $48.00B |
| High | $38.65B | $41.11B | $43.57B | $46.62B | $49.77B |
| EBITDA Avg | $2.64B | $2.80B | $2.98B | $3.18B | $3.40B |
| Low | $2.60B | $2.73B | $2.91B | $3.11B | $3.32B |
| High | $2.68B | $2.85B | $3.02B | $3.23B | $3.45B |
| EBIT Avg | $1.43B | $1.52B | $1.61B | $1.72B | $1.84B |
| Low | $1.41B | $1.48B | $1.57B | $1.68B | $1.80B |
| High | $1.45B | $1.54B | $1.63B | $1.75B | $1.87B |
| Net Income Avg | $733M | $835M | $948M | $1.18B | $1.28B |
| Low | $712M | $811M | $920M | $1.15B | $1.24B |
| High | $747M | $851M | $965M | $1.20B | $1.30B |
| EPS Avg | $1.17 | $1.33 | $1.51 | $1.88 | $2.04 |
| Low | $1.13 | $1.29 | $1.47 | $1.83 | $1.98 |
| High | $1.19 | $1.35 | $1.54 | $1.92 | $2.07 |
| Analysts (Rev / EPS) | 16 / 1 | 17 / 1 | 9 / 1 | 14 / 1 | 8 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $9.85B | $10.15B | $9.50B |
| Low | $9.79B | $10.08B | $9.44B |
| High | $9.91B | $10.21B | $9.56B |
| EBITDA Avg | $682M | $703M | $658M |
| Low | $678M | $698M | $654M |
| High | $686M | $707M | $662M |
| EBIT Avg | $369M | $380M | $356M |
| Low | $367M | $378M | $354M |
| High | $371M | $383M | $358M |
| Net Income Avg | $236M | $212M | $156M |
| Low | $234M | $211M | $154M |
| High | $237M | $214M | $157M |
| EPS Avg | $0.38 | $0.34 | $0.25 |
| Low | $0.37 | $0.34 | $0.25 |
| High | $0.38 | $0.34 | $0.25 |
| Analysts (Rev / EPS) | 2 / 1 | 1 / 1 | 1 / 1 |